EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mitophagy: an emerging therapeutic target in mitochondrial diseases

Brígida R Pinho iD, Michael R Duchen iD, Jorge M A Oliveira iD

Biochemical Journal · 08.07.2026 · 483 (7) · 1193-1220

DOI: 10.1042/bcj20260161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Journal, online erschienen am 10.06.2026. Verfasst von Brígida R Pinho und 2 weiteren Autor:innen. Beteiligte Einrichtung: UCIBIO Applied Molecular Biosciences Unit, Mitochondria and Neurobiology Lab, Faculdade de Farmácia, Universidade do Porto, 4500-313 Porto, Portugal. Hauptthemen laut MEDLINE: Mitophagy, Mitochondrial Diseases, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 211 Literaturangaben. Gefördert von: EC | European Regional Development Fund (ERDF), MEC | Fundação para a Ciência e a Tecnologia (FCT), Action Medical Research (AMR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitophagy is a crucial autophagic process that degrades dysfunctional or unnecessary mitochondria, thereby maintaining cellular homeostasis. Mitophagy occurs through both basal mitophagy and stress-induced pathways, highly regulated by a complex network of proteins. In mitochondrial diseases, which are genetic disorders lacking effective treatments, mitophagy is often defective or insufficient. This permits the accumulation of dysfunctional mitochondria that negatively impact cell homeostasis. While some experimental therapeutic strategies have enhanced mitophagy in mitochondrial disorders by targeting broadly acting signaling pathways, such as mTORC1 inhibition or AMPK activation, pharmacological approaches directly targeting the mitophagy process remain underexplored in these disorders. Given the growing understanding of mitophagy regulation, targeting key proteins involved in this process may offer novel therapeutic opportunities for mitochondrial diseases. Here, we explore the molecular mechanisms of mitophagy, examining distinct pathways and regulatory checkpoints that might present potential therapeutic targets. Additionally, we review recent studies evaluating the effects of mitophagy modulation in mitochondrial diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyMitochondrial DiseasesMitochondriaHumansAnimalsSignal TransductionMolecular Targeted TherapyAutophagy

Stichwörter der Autor:innen

autophagymitochondriapathwaypharmacologyreceptorsubiquitins

Autor:innen und Institutionen

  • UCIBIO Applied Molecular Biosciences Unit, Mitochondria and Neurobiology Lab, Faculdade de Farmácia, Universidade do Porto, 4500-313 Porto, Portugal.
  • Associate Laboratory i4HB Institute for Health and Bioeconomy, Universidade do Porto, 4500-313 Porto, Portugal.
  • Department of Cell and Developmental Biology, University College London, London WC1E 6BT, U.K.

ORCID-Profile: Brígida R Pinho, Michael R Duchen, Jorge M A Oliveira

Förderung

  • EC | European Regional Development Fund (ERDF)
  • MEC | Fundação para a Ciência e a Tecnologia (FCT)
  • Action Medical Research (AMR)

Zitieren

APA

Pinho, B. R., Duchen, M. R., & Oliveira, J. M. A. (2026). Mitophagy: an emerging therapeutic target in mitochondrial diseases. Biochemical Journal, 483(7), 1193-1220. https://doi.org/10.1042/bcj20260161

Vancouver

Pinho BR, Duchen MR, Oliveira JMA. Mitophagy: an emerging therapeutic target in mitochondrial diseases. Biochemical Journal. 2026;483(7):1193-1220. doi:10.1042/bcj20260161

BibTeX
@article{Pinho2026,
  author = {Pinho, Brígida R and Duchen, Michael R and Oliveira, Jorge M A},
  title = {Mitophagy: an emerging therapeutic target in mitochondrial diseases},
  journal = {Biochemical Journal},
  year = {2026},
  volume = {483},
  number = {7},
  pages = {1193--1220},
  doi = {10.1042/bcj20260161}
}
Kostenlos starten →